Tag: Jonathan Parr

Michael Sciaudone, MD, an infectious diseases specialist at UNC, has won a 2021 postdoctoral fellowship in tropical infectious diseases from the Burroughs Wellcome Fund-American Society of Tropical Medicine & Hygiene (ASTMH). Three of the coveted fellowships are awarded nationally each year, funding research focused on low and low-middle income countries....

Hepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective childhood vaccines. In the Democratic Republic of the Congo, HBV treatment and birth-dose vaccination programs are not established. UNC School of Medicine researchers led a study to evaluate the feasibility and acceptability of HBV testing...

The year was 1993. Alexis Mwanza, then 17, found himself huddled on top of a train, fleeing violence in his home town in the Democratic Republic of Congo by leading nine of his family members 500 miles away to Mbuji Mayi. As a displaced refugee in that city, Mwanza watched...

“There are few people like him,” as a long-term collaborator and friend said. “Steve was so humble and generous that I don’t think he really understood the impact he had on the people around him. He profoundly changed for the better the lives of so many people he worked with...

By the spring of 2020, the urgency of the COVID-19 pandemic caused many researchers affiliated with UNC’s Institute for Global Health and Infectious Diseases to pivot their studies to focus on testing, treatment and prevention of the SARS-CoV-2 virus. Here, a look at some of the projects underway in the...

  In the first COVID-19 case series of tocilizumab in the United States, UNC-Chapel Hill researchers report sobering results. They say the drug should be used judiciously until randomized clinical trials determine tocilizumab’s true efficacy. Meanwhile, medical students sidelined from clinical rotations by the virus conducted the research with lightning...